Dana-Farber Cancer Institute
The following description was provided by the Dana-Farber Cancer Institute:
Ever since Sidney Farber, MD, pioneered chemical therapies to treat children with leukemia in 1947, Dana-Farber has forged a groundbreaking path: 70+ years of research discovery and innovation have revolutionized cancer diagnosis and treatment, for the benefit of all their patients, adult and pediatric. Dana-Farber's equal emphasis on patient care and research means that their leading-edge research is informed by patient care – and their patient care relies on leading-edge research.
Browse available plasmids from each Dana-Farber PI listed below.
Resources
- More information on Dana-Farber Cancer Institute
- Addgene Blog Posts or Newsletter Articles featuring technologies from the Dana-Farber:
Dana-Farber Cancer Institute Sharing Statistics
50 Depositing Scientists
Sharing 2,551 Reagents
Requested 63,627 Times
Shipped to 76 Countries